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Distribution of Calcium in the Ascending Aorta in
Patients Undergoing Transcatheter Aortic Valve
Implantation and Its Relevance to the
Transaortic Approach
Vinayak N. Bapat, FRCS.CTH, Rizwan Q. Attia, MRCS, Martyn Thomas, FRCP
London, United Kingdom
Objectives This study sought to identify how many patients suitable for transcatheter aortic valve
implantation (TAVI) would have a contraindication for the transaortic (TAo) approach due to ascend-
ing aortic calciﬁcation.
Background TAo is an emerging approach for implantation of the Sapien valve through the as-
cending aorta. A “porcelain aorta” is often considered a contraindication for the TAo approach. This
may not always be true, as the TAo procedure requires a small calcium-free area for the purse-string su-
ture, usually in the upper outer quadrant of the distal ascending aorta, identiﬁed as the “TAo zone.”
Methods A total of 237 patients underwent TAVI between February 2008 and June 2011. Multislice
computed tomography scans (MSCT) were analyzed for distribution of calcium with special attention
to the TAo zone. Each MSCT was interrogated in cross section and three dimensional (3D) recon-
structions. Correlation between the calcium distribution on MSCT and the 3D reconstruction with
the clinical ﬁndings was sought in patients undergoing the TAo procedure.
Results The vast majority of patients had calciﬁcation in the aortic arch (n  154, 64.9%) and aortic
root (n  220, 92.8%). Of the 237 patients, only 1 patient had diffuse calciﬁcation in the ascending
aorta, including the TAo zone, thus precluding a TAo procedure. MSCT and 3D reconstruction data
in the 33 patients who underwent a TAo procedure, including 6 who were identiﬁed as having por-
celain aorta preoperatively, correlated very well with the absence of calcium in the TAo zone during
surgery. There were no post-procedure neurological events in this group.
Conclusions Conventionally deﬁned porcelain aorta should not be considered a contraindication
for performing TAVI by the TAo approach. (J Am Coll Cardiol Intv 2012;5:470–6) © 2012 by the
American College of Cardiology Foundation
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471Aortic calcification is present in various degrees in almost
all patients with atherosclerotic plaques. The incidence
varies with the diagnostic method used but lies between
14% and 29% (1). The main risk during cardiac surgery is
the occurrence of stroke due to embolization of athero-
matous material caused by manipulation of the ascending
aorta. Porcelain aorta is at the extreme end of this
spectrum and is defined as near-circumferential calcifica-
tion of the aorta. Although rare (1% to 2%), it poses a
unique problem for the surgeons (1,2). The distribution
of calcium in the ascending aorta can prevent clamping,
cannulation, aortotomy, and/or construction of the prox-
imal anastomosis and is associated with a higher inci-
dence of stroke (3).
For isolated coronary disease, if surgery is the only option,
then an “off-pump,” no-touch strategy can be employed (3).
However, no such options exist for valve surgery other than
performing aortic valve and/or ascending aortic replacement
under circulatory arrest or performing an apicoaortic con-
duit (1,3). These options carry a higher surgical and stroke
risk (3). Transcatheter aortic valve implantation (TAVI) has
emerged as an excellent option for these patients, and
successful implantations have been reported using both the
conventional approaches, that is, the transapical (TA) and
the transfemoral (TF) (4,5).
We have described earlier an alternative approach, that is,
the transaortic route (TAo) for TAVI (6,7). This procedure
involves performing the procedure through a purse-string
suture on the ascending aorta. As it is devoid of clamping
and cutting the aorta, the traditional definition of porcelain
aorta may not be a contraindication for this procedure. This
paper aims to examine the distribution of calcium in the
ascending aorta in patients undergoing TAVI using mul-
tislice computed tomography (MSCT) and 3-dimensional
(3D) reconstruction with special reference to the subset of
patients who were identified as having a porcelain aorta, to
identify the percentage of patients who have a true contra-
indication for the TAo technique of TAVI and to deter-
mine the accuracy of 3D computed tomography (CT) scan
by correlating these with the clinical findings during the
procedure.
Methods
All consecutive patients undergoing TAVI at our insti-
tute over a 3-year period (February 2008 to June 2011)
were included and analyzed. The multidisciplinary heart
valve team assessed all referred patients. Pre-operative
assessment includes full clinical and laboratory assess-
ment, transthoracic echocardiography, chest x-ray, coro-
nary angiography, carotid Doppler ultrasound, and non-
contrast MSCT. Identification of porcelain aorta in a
patient was based on fluoroscopy and cross-sectional
MSCT images.Calcium mapping. The ascend-
ing aorta was divided into 3
segments, proximal third—from
the aortic annulus to the sinotu-
bular junction, middle third—
from the sinotubular junction to
5 cm from annulus, and distal
third—from 5 cm to origin of
the innominate artery. Each seg-
ment was further divided into 4
quadrants—anterior, medial,
posterior, and lateral (Fig. 1), thus dividing the ascending
aorta into 12 zones. The “TAo zone” corresponds to the
lateral quadrant and part of the anterior quadrant of the
distal third of the ascending aorta. Calcification in the aortic
arch (region of the aorta where the 3 head and neck vessels
originate) was also documented. All MSCT scans were
transferred to and analyzed in detail using the OsiriX MD
software (OsiriX, San Antonio, Texas). Mapping of ascend-
ing aortic calcification was carried out with aortic segmen-
tation on MSCT for all patients. Two-dimensional scans
were reviewed on coronal and sagittal projections on a
slice-by-slice basis to determine the exact location and
quantity of calcium in the aortic wall (Figs. 2A and 2B).
This included maximum intensity projection and multipla-
nar reconstructions (Figs. 2C and 2D). The availability of
volumetric data allowed further processing and generation
of 3D volume-rendered reconstructions to assess the ab-
sence of calcification in the TAo zone (Figs. 3A and 3B). A
Abbreviations
and Acronyms
3D  3-dimensional
MSCT  multislice
computed tomography
TA  transapical
TAo  transaortic
TAVI  transcatheter aortic
valve implantation
TF  transfemoral
Figure 1. Zones of Ascending Aorta Used for Calcium Mapping
A schematic representation of 3 segments of the ascending aorta (proxi-
mal, middle, and distal), which are further divided into 4 quadrants
(A  anterior; L  lateral; M  medial; P  posterior), thus resulting in
12 zones.
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472calcium score could also be calculated, if required, to
quantify the amount of calcium. We were interested in
mapping the region and surface area covered by calcium but
not to quantify the degree of calcification, as the presence of
any calcium would preclude that site being used for aortic
cannulation. MSCT and 3D reconstructions were used in
Figure 2. MSCT Interrogation for Calcium Mapping
(A) Transverse section of computed tomography (CT) scan through the ascend
(C and D) Maximum intensity projection and multiplanar reconstructions of th
Figure 3. 3D Volume Rendering of MSCT Data
The 3-dimensional (3D) volume-rendered reconstructions to allow the map-
ping of ascending aortic calciﬁcation and to determine absence of calcium
in the transaortic zone. (A) Extensive calciﬁcation of the entire aorta.
(B) Calciﬁcation in the aortic root, part of the ascending aorta and arch.
MSCT  multislice computed tomography.selecting cases suitable for the TAo approach, that is, when
the TAo zone was free of calcium. This was confirmed
during the operation with digital palpation.
TAo TAVI. The detailed description of the TAo approach is
beyond the scope of this paper and has been previously
published (6,7). In relation to aortic anatomy, TAo TAVI is
performed through a purse-string suture on the aorta, which
is placed in an area of the ascending aorta that: 1) is free of
calcification; 2) allows the operator to direct the sheath in a
straight line to deploy the device; and 3) leaves enough room
between the tip of the sheath and the native aortic valve
annulus to allow the balloon to expand fully during deploy-
ment of the device (Fig. 4). When using the Edwards
Sapien device (Edwards Lifesciences, Irvine, California),
this is usually a point that is 5 cm from the aortic annulus
along the greater curvature of the upper outer quadrant of
the aorta, a region that we refer to as the TAo zone
(Fig. 4). Thus, the TAo zone is defined as a zone in the
anterior and lateral quadrant of the ascending aorta
beyond 5 cm from the annulus. When using the CoreValve
(Medtronic, Minneapolis, Minnesota), one needs to puncture
the aorta 6 to 7 cm from the aortic annulus. This is because the
height of a crimped CoreValve is 6.5 cm, but as the valve is
deployed, the stent shortens to its final height, which is 5.2 to 5.5
rta. (B) Sagittal section of the CT scan through the ascending aorta.
a used for the calcium mapping. MSCT  multislice computed tomography.ing aocm, depending on the size of the device chosen.
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473Statistics. Statistical analysis was carried out using the SPSS
tatistics software version 10.0 (IBM, Armonk, New York).
ata are presented as mean  SD, and confidence intervals
or patient variables.
esults
Baseline characteristics. There were 237 patients, of whom
03 (43.4%) had TF, 101 (42.6%) had TA, and 33 (14%)
ad the TAo approach for TAVI. The mean age at
rocedure was 82  8.7 years, and the female-to-male ratio
as 2:1. All the baseline demographic parameters are
utlined in Table 1.
Figure 4. The TAo Zone
A schematic representation of the transaortic (TAo) zone of the ascending aor
Table 1. Demographics and Comorbidities (N  237)
TF
(n  1
Mean age, yrs 82.
Age range, yrs 57–9
Female/male 1.86
COPD 9 (8.7
Severe extracardiac arteriopathy 3 (1.6
Carotid arteriopathy 50% 12 (11
Previous CABG 24 (23
Pulmonary hypertension (moderate–severe) 6 (5.8
NYHA functional class III to IV 51 (49
CCS class III to IV 2 (1.9
Serum creatinine, mg/dl 109.8
Mean LVEF, % 48
Logistic EuroSCORE 19.
Values are mean, range, n (%) or mean SD.
CABG coronary artery bypass grafting; CCSCanadian Cardiac Soejection fraction; NYHA New York Heart Association; TA transapical; TAoCalcium mapping. The vast majority of patients had calci-
cation in the aortic arch (Table 2). Porcelain aorta patients
ad more calcium burden than the nonporcelain aorta
atients in all 12 segments of the ascending aorta and the
ortic arch (Table 2). None of the nonporcelain aorta
atients (n  220) had calcification in the TAo zone of the
scending aorta, which would prevent a safe TAo approach
or TAVI. Of the 17 patients with porcelain aorta (TA 
0, TF  1, TAo  6), only 1 patient was found to have
iffuse calcification in the ascending aorta including the
Ao zone, thus precluding a TAo procedure (Fig. 5). This
atient had undergone a TF procedure without any neurolog-
red).
TA
(n  101)
TAo
(n  33) Total
82.1 81.7 82.0
29–94 44–94 29–96
2:1 2:1 1.95:1
14 (13.8%) 12 (36.3%) 35 (14.7%)
12 (11.8%) 7 (18.7%) 22 (7.3%)
25 (24.7%) 12 (34.3%) 49 (20.6%)
34 (33.6%) 7 (21.2%) 65 (27.4%)
12 (11.8%) 5 (15.1%) 23 (9.7%)
73 (72.2)% 33 (100%) 157 (66.2%)
7 (6.8%) 5 (15.1%) 14 (5.9%)
121 16.4 130 25.5 120.2 17.5
48 49 48
24.8 34.4 26.2
OPD chronic obstructive pulmonary disease; LVEF left ventricular03)
3
6
:1
%)
5%)
.6%)
.3%)
%)
.5%)
%)
10.7
4
ciety; C transaortic; TF transfemoral.
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474ical sequelae. Absence of calcium in the TAo zone in all 33
patients who underwent a TAo procedure, including 6 of 17
with porcelain aorta, correlated very well with the operative
findings. None of the patients who underwent TAo TAVI had
post-operative neurological events.
Discussion
In the presence of a porcelain aorta, conventional aortic
valve surgery can be technically demanding and is asso-
ciated with a heavy burden of morbidity and mortality
Table 2. Calcium Distribution in 12 Zones of the Ascending Aorta I
Anatomical
Aortic Segment Quadrant
Calcification (%)
Nonporcelain Aorta
(n  220)
Porcelain Aorta
(n  17)
Proximal third Anteriomedial 70 88.2
Posteriomedial 57.2 82.3
Posteriolateral 62.7 83.3
Anteriolateral 43.6 88.2
Middle third Anteriomedial 1 47
Posteriomedial 3.6 41
Posteriolateral 0.4 6
Anteriolateral 0.4 23.5
Distal third Anteriomedial 33.6 53
Posteriomedial 19 82.3
Posteriolateral 30 70.5
Anteriolateral 0 5.8
Aortic arch 54.5 70.5
Figure 5. Case Study to Demonstrate Contraindication for TAo TAVI
A 3D reconstruction of MSCT demonstrating diffuse calciﬁcation in the
entire ascending aorta, including the TAo zone, thus unsuitability for the
TAo approach. TAVI  transcatheter aortic valve implantation; other abbre-
viations as in Figures 3 and 4.(8). It may be technically impossible for the surgeon to
cannulate the aorta for cardiopulmonary bypass safely
and/or to cross clamp the aorta. In addition, it may be
impossible to perform an aortotomy to access the aortic
valve. Hence, for conventional aortic valve replacement,
the options are either replacement of the aortic valve and,
if necessary, the ascending aorta under deep hypothermic
circulatory arrest or an apicoaortic conduit to bypass the
aortic stenosis (9 –11). This also explains the higher risk
of complications, including stroke (8,9).
Patients with porcelain aorta have benefited from
TAVI technology. TAVI has been performed through
the TF, TA, and subclavian routes in these patients
(12–15). The incidence of stroke varies from 4% to 10%
(12–15). Kempfert et al. (16) have published their expe-
rience with TA in 29 patients who were identified as
having a porcelain aorta, using the Edwards Sapien valve.
The 30-day mortality was 17.2% with a stroke rate of
3.5%. Buz et al. (17) also evaluated the TA-TAVI in 46
patients with severe aortic calcification. In this series,
there was no reported 30-day mortality, with 6- and
12-month survival at 88% and 85.2%, respectively. Brain
CT demonstrated new cerebral ischemia in 6.2% of
patients, with 1 patient (2.1%) experiencing a stroke.
Both the reports, however, do not comment on the
distribution and the burden of calcium in the ascending
aorta, and hence, it is unclear how many of these would
be unsuitable for the TAo approach. In our series, none
of our TAo patients (n  33), including those with a
porcelain aorta, (6 of 33), had calcification in the TAo
zone; they underwent TAo TAVI without neurological
sequelae (Table 3).
The incidence of significant atherosclerotic aorta varies
widely from 1.2% to 25% of the population, where, at the
severe end of the spectrum, porcelain aorta affects 1% to
5% of patients (1,2). However, identification of a porce-
lain aorta is largely subjective and hence probably ex-
plains the high incidence reported in the TAVI literature
Table 3. Early Patient Outcome After TAVI
TF
(n  103)
TA
(n  101)
TAo
(n  33) Overall
Early mortality 7 (6.7%) 7 (6.9%) 2 (6.0%) 16 (6.7%)
New neurological dysfunction 4 (3.8%) 6 (5.9%) 0 (0%) 10 (4.2%)
PPM 2 (1.9%) 3 (2.9%) 0 (0%) 5 (2.55)
Renal failure 6 (5.8%) 13 (12.8%) 4 (12.1%) 23 (9.7%)
Major vascular bleeding 7 (6.7%) 3 (2.9%) 1 (3.0%) 11 (4.6%)
Chest sepsis 7 (6.7%) 5 (5.9%) 2 (6.0%) 14 (5.9%)
ICU stay, days 1 1 0 1
Values are n (%) or median.
ICU  intensive care unit; PPM  prosthesis-patient mismatch; TAVI  transcatheter aortic
valve implantation; other abbreviations as in Table 1.(ranging from 10% to 35%) (13–15,17). Fluoroscopy can
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475be inaccurate in diagnosing a porcelain aorta and at times
may fail to show important areas of calcification. This
was demonstrated in a clinical case in our series. A
63-year-old patient in our cohort was due for a conven-
tional aortic valve replacement. Fluoroscopy demon-
strated some calcification near the left main but no hint
of a porcelain aorta (Fig. 6A). On sternotomy, it was
discovered that the patient had severe ascending aortic
calcification, which made aortic cross-clamping impossi-
ble. There was, however, absence of calcium in the
anterior wall, especially in the TAo zone. This is dem-
onstrated very well using 3D reconstruction of his MSCT
scan (Figs. 6B and 6C). Hence, the patient underwent an
mmediate conversion to TAo TAVI with an excellent
ost-procedure result.
MSCT scans have been shown to accurately identify
alcification easily. A 3D reconstruction of the MSCT
sing OsiriX MD software allows an objective assessment
f calcium distribution in the ascending aorta and allows
easurement of the distance between the aortic annulus
Figure 6. Case Study to Demonstrate Inaccuracy of Fluoroscopy in Detect
(A) Fluoroscopy demonstrating absence of porcelain aorta. (B) Previous nonco
calcium in the anterior wall and TAo zone of the ascending aorta. Abbreviatio
Figure 7. Case Study to Demonstrate That Traditional Definition of Porcela
(A) Cross-sectional computed tomography scan shows concentric calciﬁcation
hence suitability for the TAo approach. Abbreviations as in Figures 3 and 4.and the proposed site of cannulation, that is, the TAo
zone (Fig. 7). It has been shown to correlate accurately
with the clinical findings (18). Hence, we routinely use
MSCT and its 3D reconstruction in selecting patients for
the TAo approach. In the vast majority of our patients,
this constitutes a noncontrast MSCT that has no impact
on the renal system. This was especially evident in the 6
patients who were identified as having a porcelain aorta
on fluoroscopy and cross-sectional CT but had a calcium-
free TAo zone on 3D reconstruction and hence under-
went TAo without neurological events (Fig. 7).
Epiaortic scanning has also been used to detect calcifica-
tion and plaques in the aorta during open-heart surgery.
Van der Linden et al. (19) conducted a very elegant study to
correlate the location and extent of calcium in the ascending
aorta with post-operative stroke during/after cardiac sur-
gery. Epiaortic scanning of the ascending aorta was per-
formed in 921 consecutive patients who underwent cardiac
surgery. The aorta was divided into 12 segments in total.
The presence of aortic atheroma (intimal thickening 0.5
lcification
MSCT demonstrated the heavily calciﬁed ascending aorta. (C) Absence of
n Figures 3 and 4.
rta Is Not a Contraindication for TAo TAVI
ascending aorta. (B) 3D reconstructions demonstrates calcium-free TAo zoneing Ca
ntrastin Ao
in the
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476mm) and calcification were recorded for each segment.
Extent of disease was defined as the number of segments
concomitantly involved. A total of 26.2% of the patients had
atherosclerosis of the ascending aorta, and in 44% of these,
more than 1 of 12 possible segments were involved. The
incidence of stroke was 1.8% in patients without atheroscle-
rotic disease of the ascending aorta, and 8.7% in patients
with the disease (p  0.0001). Of interest was the lower
incidence and intensity of atheroma in the middle and distal
lateral segments (which correspond to the TAo zone) when
compared with other segments (9.4% and 15.7%, respec-
tively) (19). A few other groups also advocate the routine
use of epiaortic scanning to choose the site of aortic
cannulation during open-heart surgery to reduce the inci-
dence of stroke (20,21). However, most of this literature
predates the widespread use of MSCT that is now a routine
investigation in the assessment of patients undergoing
TAVI. There is also the easy ability to reconstruct the
images to map the aorta in 3D. This allows the clinician to
plan the procedure in advance and anticipate problems.
The analysis of MSCT data in our patients indicates that
TAo is not necessarily contraindicated in patients with
extensive aortic calcification if the TAo-zone is free of
plaques and the absence of calcification on MSCT correlates
accurately with clinical findings during surgery.
Conclusions
Distribution of calcium in the ascending aorta should be
analyzed with MSCT in every patient undergoing TAVI. A
3D reconstruction allows accurate identification and distri-
bution of calcium in the ascending aorta, especially the TAo
zone. Conventional definition of porcelain aorta should not
be considered a contraindication for performing a TAo
procedure if the TAo zone is free of calcium.
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